Showing results (301-310 of 443) with videos related to

Sort By:
Pageof 45
Pharmacology & Therapeutics|May 16, 2021
Advances in immunotherapeutic targets for childhood cancers: A focus on glypican-2 and B7-H3Nan Li, Madeline R Spetz, Dan Li, et al.
Current Protocols|January 3, 2023
Humanization of the Shark VNAR Single Domain Antibody Using CDR GraftingYi-Fan Zhang, Yaping Sun, Jessica Hong, et al.
Trends in Cancer|October 25, 2018
Glypicans as Cancer Therapeutic TargetsNan Li, Wei Gao, Yi-Fan Zhang, et al.
Oncology Letters|March 21, 2020
Diffuse mesothelin expression leads to worse prognosis through enhanced cellular proliferation in colorectal cancerSatoshi Inoue, Takumi Tsunoda, Miho Riku, et al.
Molecular Cancer Therapeutics|December 25, 2019
Site-Specific PEGylation of Anti-Mesothelin Recombinant Immunotoxins Increases Half-life and Antitumor ActivityZeliang Zheng, Ryuhei Okada, Hisataka Kobayashi, et al.
Nuclear Medicine and Biology|November 28, 2002
Lowering of pI by acylation improves the renal uptake of 99mTc-labeled anti-Tac dsFv: effect of different acylating reagentsInsook Kim, Hisataka Kobayashi, Tae M Yoo, et al.
Nuclear Medicine and Biology|December 17, 2011
Combined-modality radioimmunotherapy: synergistic effect of paclitaxel and additive effect of bevacizumabBeom-Su Jang, Sang-Myung Lee, Hyung Sub Kim, et al.
Kidney International|July 16, 2017
Tubulointerstitial fibrosis can sensitize the kidney to subsequent glomerular injuryBeom Jin Lim, Jae Won Yang, Jun Zou, et al.
Pageof 45